First Header Logo Second Header Logo

Geographic and Demographic Variation in Use of Ranibizumab Versus Bevacizumab for Neovascular Age-related Macular Degeneration in the United States.

Gower EW, Stein JD, Shekhawat NS, Mikkilineni S, Blachley TS, Pajewski NM. Geographic and Demographic Variation in Use of Ranibizumab Versus Bevacizumab for Neovascular Age-related Macular Degeneration in the United States. Am J Ophthalmol. 2017 Dec; 184:157-166.

View in: PubMed